Previous Statements by CPHD
» Cepheid Q1 2009 Earnings Call Transcript
» Cepheid, Q4 2008 Earnings Call Transcript
» Cepheid F3Q08 (Qtr End 09/30/08) Earnings Call Transcript
Cepheid's (CPHD) stock rating was cut to 'neutral' at Baird on Monday morning.
Barclays hiked Cepheid's (CPHD) stock price target to $52 on Wednesday after Danaher (DHR) agreed to buy the company for $4 billion yesterday.
Potential targets of the medical device and diagnostics giant might request stricter parameters when structuring a deal, company followers say.
Mergers and high-growth stocks are making the market better and better, Cramer says.